Mirion Technologies Announces Pricing of Public Offering by Selling Stockholders
March 02 2023 - 10:00PM
Business Wire
Mirion Technologies, Inc. (“Mirion,” “we” or the “company”)
(NYSE: MIR), a global provider of radiation detection, measurement,
analysis and monitoring solutions to the medical, nuclear, defense,
and research end markets, today announced the pricing of an
underwritten public offering of 9,786,153 shares of Mirion’s Class
A common stock by certain selling stockholders at a price to the
public of $8.75 per share. Selling stockholders participating in
the offering consist of entities affiliated with Charterhouse
Capital Partners. Mirion will not sell any securities in the public
offering and will not receive any of the proceeds from the sale of
the shares being offered by the selling stockholders but Mirion
will bear the costs associated with the public offering, other than
underwriting discounts and commissions and certain other expenses.
The offering is expected to close on March 7, 2023, subject to
customary closing conditions.
Jefferies is acting as the sole bookrunner for the offering.
The offering is being made pursuant to a shelf registration
statement, including a base prospectus, declared effective by the
Securities and Exchange Commission (the “SEC”) on November 28,
2022. Before you invest, you should read the prospectus in the
registration statement and the other documents Mirion has filed or
will file with the SEC for more complete information about Mirion
and this offering. The proposed offering is being made only by
means of an effective shelf registration statement, including a
base prospectus and final prospectus supplement, copies of which
may be obtained, when available, free of charge at the SEC’s
website at www.sec.gov or by contacting When available, copies of
the prospectus supplement and accompanying prospectus related to
the Offering may also be obtained from Jefferies LLC, at Attention:
Equity Syndicate Prospectus Department, 520 Madison Avenue, New
York, New York 10022, by telephone at 877-821-7388, or by email at
prospectus_department@jefferies.com.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy these securities, nor shall there
be any offer or sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to the registration or qualification under the
securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Words such as “anticipate,” “believe,” “continue,” “could,”
“estimate”, “expect”, “hope”, “intend”, “may”, “might”, “should”,
“would”, “will”, “understand” and similar words are intended to
identify forward looking statements. These forward-looking
statements include but are not limited to, statements regarding the
closing of the public offering. Actual results may differ
materially from those described in the forward-looking statements
and will be affected by a variety of risks and factors that are
beyond our control including, without limitation, market risks and
uncertainties and the satisfaction of customary closing conditions
for an offering of securities, and other risks set forth under the
heading “Risk Factors” in Mirion’s filings with the Securities and
Exchange Commission (the “SEC”) from time to time, including our
Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and
other periodic reports filed or to be filed with the SEC.
You should not rely on these forward-looking statements, as
actual outcomes and results may differ materially from those
contemplated by these forward- looking statements as a result of
such risks and uncertainties. All forward-looking statements in
this press release are based on information available to us as of
the date hereof, and Mirion does not assume any obligation to
update the forward-looking statements provided to reflect events
that occur or circumstances that exist after the date on which they
were made.
About Mirion
Mirion Technologies is a leading provider of detection,
measurement, analysis and monitoring solutions to the nuclear,
defense, medical and research end markets. The organization aims to
harness its unrivaled knowledge of ionizing radiation for the
greater good of humanity. Headquartered in Atlanta (GA – USA),
Mirion employs approximately 2,800 people and operates in 13
countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230302005940/en/
For investor inquiries: Jerry Estes ir@mirion.com
For media inquiries: Matthew Maddox
mmaddox@mirion.com
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From May 2024 to Jun 2024
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From Jun 2023 to Jun 2024